-
1
New-Onset Lichen Planus Induced by the Pfizer COVID-19 Vaccine
Published 2022-01-01“…New-onset lichen planus appeared 48 hours after the first dose of the Pfizer vaccine. The symptoms worsened following the second dose. …”
Get full text
Article -
2
Liver Functions in Type 2 Diabetes Individuals after Pfizer Vaccination in Iraqi Patients
Published 2022-09-01“…The current research concludes that there is no effect of the Pfizer vaccine on a biochemical parameter of the liver. …”
Get full text
Article -
3
Delayed-onset anaphylaxis after first dose of Pfizer-BioNTech COVID-19 vaccine
Published 2023-09-01Get full text
Article -
4
A Rare Cutaneous Manifestation: Leukocytoclastic Vasculitis after Pfizer-BioNTech COVID-19 Vaccination
Published 2022-01-01“…We present a case of an 81-year-old male evaluated in the emergency department for a bilateral purpuric non-blanching rash that appeared ten days after receiving the Pfizer-BioNTech booster vaccine against SARS-CoV-2. …”
Get full text
Article -
5
Estimating the Effectiveness of Pfizer and Sinopharm Vaccines and their Relationship to Occupation, Residence, Smoking, and Body Mass Index During Pregnancy Smoking
Published 2025-01-01Subjects: “…Pfizer vaccine…”
Get full text
Article -
6
Comparison of IgG and Neutralizing Antibody Response After Pfizer BioNTech COVID-19 Vaccine Among Iraqi Individuals
Published 2023-06-01“…A total of 41 vaccinated individuals with Pfizer-BioNTech COVID-19 vaccine, as well as (10) non vaccinated were included in the study. …”
Get full text
Article -
7
-
8
COVID-19 Vaccines Effectiveness and Safety in Trinidad and Tobago: A Systematic Review and Meta-Analysis
Published 2025-01-01Subjects: “…Pfizer-BioNTech…”
Get full text
Article -
9
Case report: Development of anxiety symptoms after receiving the Pfizer-BioNTech (BNT162b2) COVID-19 vaccine: a case series
Published 2025-01-01“…This article describes three patients who reported anxiety after receiving a complete course of the Pfizer-BioNTech BNT162b2 vaccine. It is important to explore the relationship between anxiety, other mental health disorders, and COVID-19 vaccination, as well as to investigate potential pathogenetic mechanisms.…”
Get full text
Article -
10
Efficacy of BNT162b2 and CoronaVac in patients diagnosed with COVID-19
Published 2023-06-01Subjects: Get full text
Article -
11
-
12
-
13
Favorable Nonclinical Safety Profile of RSVpreF Bivalent Vaccine in Rats and Rabbits
Published 2024-12-01“…<b>Background</b>: Respiratory syncytial virus (RSV) infections usually cause mild, cold-like symptoms in most people, but are a leading infectious disease causing infant death and hospitalization and can result in increased morbidity and mortality in older adults and at-risk individuals. Pfizer has developed Abrysvo<sup>®</sup>, an unadjuvanted bivalent recombinant protein subunit vaccine containing prefusion-stabilized fusion (F) proteins representing RSV A and RSV B subgroups (RSVpreF). …”
Get full text
Article -
14
Tick-borne encephalitis vaccine uptake, effectiveness, and impact in Sweden from 2018 to 2022
Published 2025-01-01Get full text
Article -
15
-
16
-
17
-
18
-
19
The need for novel influenza vaccines in low- and middle-income countries: A narrative review
Published 2025-01-01Get full text
Article -
20